Insider Transactions in Q1 2024 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2024
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,038
-2.02%
|
$112,532
$14.24 P/Share
|
|
Jan 02
2024
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,392
+12.6%
|
-
|
|
Jan 02
2024
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
144,628
+12.04%
|
-
|
|
Jan 02
2024
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,331
-2.13%
|
$88,634
$14.24 P/Share
|
|
Jan 02
2024
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,209
+13.95%
|
-
|
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,985
-1.72%
|
$97,790
$14.24 P/Share
|
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,131
+13.47%
|
-
|
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.06%
|
$420,000
$14.21 P/Share
|
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.46%
|
$150,000
$5.16 P/Share
|
|
Jan 02
2024
|
Simon N.R. Harford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,392
+25.88%
|
-
|
|
Jan 02
2024
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-1.06%
|
$18,382
$14.24 P/Share
|
|
Jan 02
2024
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,252
+16.94%
|
-
|